Rare bone disease e-learning

Prof. Eric Rush has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Alexion, AstraZeneca Rare Disease, Ultragenyx, BioMarin, Inozyme, Ipsen, Aruvant, Ascendis, Intercept, Spectrum

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Assoc. Prof. Marelise Eekhoff

Prof. Dr Oliver Semler

Prof. Eric Rush

Dr Kassim Javaid

Ms. Charlene Waldman

Ms. Inês Alves

Dr Zulf Mughal

I agree that this educational programme:

Assoc. Prof. Marelise Eekhoff

Prof. Dr Oliver Semler

Prof. Eric Rush

Dr Kassim Javaid

Ms. Charlene Waldman

Ms. Inês Alves

Dr Zulf Mughal

Programme summary

Supporter Acknowledgement

Accreditation

I agree that this educational programme:

Other programmes of interest

Rethinking hypophosphatasia (HPP) and systemic impacts of deficient alkaline phosphatase activity

Rethinking hypophosphatasia (HPP): New perspectives on diagnosis and disease burden

Short-stature conditions, including SPIGFD

Experts

Endorsed by

Neuroendocrine tumours (NETs) shared decision-making: Exploring the patient journey and individualising treatments

Experts

Endorsed by

Tools for optimising treatment & management of advanced NETs

Experts

Endorsed by

Chronic hypophosphatemia: Differential diagnosis in children and adults

Experts

Rare bone disease e-learning

Assoc. Prof. Marelise Eekhoff

Prof. Dr Oliver Semler

Prof. Eric Rush

Dr Kassim Javaid

Ms. Charlene Waldman

Ms. Inês Alves

Dr Zulf Mughal

Publication Date

I agree that this educational programme:

Assoc. Prof. Marelise Eekhoff Internist endocrinologist Rare Bone Disease Center, Amsterdam University Medical Centers Netherlands (NL)

Assoc. Prof. Marelise Eekhoff

Prof. Dr Oliver Semler Paediatric Rheumatologist Children’s Hospital, University of Cologne, Cologne Germany (DE)

Prof. Dr Oliver Semler

Prof. Eric Rush Clinical Geneticist Children’s Mercy, Kansas City, MO United States (US)

Prof. Eric Rush

Disclosures

Dr Kassim Javaid Rheumatologist Oxford University Hospitals, Oxford United Kingdom (GB)

Dr Kassim Javaid

Ms. Charlene Waldman Patient advocacy Rare Bone Disease Alliance, Connecticut United States (US)

Ms. Charlene Waldman

Ms. Inês Alves Patient advocacy European Rare Bone Forum, Lisbon Portugal (PT)

Ms. Inês Alves

Dr Zulf Mughal Paediatric bone disease specialist Royal Manchester Children’s Hospital, Manchester United Kingdom (GB)

Dr Zulf Mughal

Programme summary

Share this programme

Supporter Acknowledgement

Accreditation

I agree that this educational programme:

Other programmes of interest

Rethinking hypophosphatasia (HPP) and systemic impacts of deficient alkaline phosphatase activity

Rethinking hypophosphatasia (HPP): New perspectives on diagnosis and disease burden

Short-stature conditions, including SPIGFD

Experts

Endorsed by

Neuroendocrine tumours (NETs) shared decision-making: Exploring the patient journey and individualising treatments

Experts

Endorsed by

Tools for optimising treatment & management of advanced NETs

Experts

Endorsed by

Chronic hypophosphatemia: Differential diagnosis in children and adults

Experts